Seer Inc
SEER
About: Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
Employees: 134
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
27% more capital invested
Capital invested by funds: $46.6M [Q1] → $59M (+$12.4M) [Q2]
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
1% more funds holding
Funds holding: 67 [Q1] → 68 (+1) [Q2]
10% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 21
0.98% more ownership
Funds ownership: 49.41% [Q1] → 50.39% (+0.98%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]
Financial journalist opinion
Based on 3 articles about SEER published over the past 30 days